0.449 -0.001 (-0.24%) | 07-26 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 0.57 | 1-year : | 0.64 |
Resists | First : | 0.48 | Second : | 0.55 |
Pivot price | 0.45 ![]() |
|||
Supports | First : | 0.38 | Second : | 0.32 |
MAs | MA(5) : | 0.46 ![]() |
MA(20) : | 0.44 ![]() |
MA(100) : | 0.46 ![]() |
MA(250) : | 0.37 ![]() |
|
MACD | MACD : | 0 ![]() |
Signal : | 0 ![]() |
%K %D | K(14,3) : | 53.8 ![]() |
D(3) : | 62.8 ![]() |
RSI | RSI(14): 49 ![]() |
|||
52-week | High : | 0.91 | Low : | 0.25 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ IGC ] has closed above bottom band by 48.6%. Bollinger Bands are 54% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 0.46 - 0.47 | 0.47 - 0.47 |
Low: | 0.43 - 0.44 | 0.44 - 0.44 |
Close: | 0.44 - 0.45 | 0.45 - 0.45 |
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. It operates through two segments, Infrastructure and Life Sciences. The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand. The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts. It operates in the United States, India, Colombia, and Hong Kong. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Wed, 12 Jun 2024
Toronto’s Anson Funds reaches settlement with U.S. regulator over short-selling practices - The Globe and Mail
Wed, 06 Dec 2023
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials - Business Wire
Tue, 21 Nov 2023
IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives - Business Wire
Thu, 06 Jul 2023
IGC Pharma Announces a $3 Million Private Placement of its Common Stock - Business Wire
Mon, 20 Mar 2023
IGC Announces Rebranding, Changes Name to IGC Pharma, Inc. - GlobeNewswire
Wed, 23 Mar 2022
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors - citybiz
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
AMEX
|
|
Sector:
Industrials
|
|
Industry:
Conglomerates
|
|
Shares Out | 64 (M) |
Shares Float | 51 (M) |
Held by Insiders | 18.4 (%) |
Held by Institutions | 4.4 (%) |
Shares Short | 936 (K) |
Shares Short P.Month | 970 (K) |
EPS | -0.21 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.21 |
Profit Margin | 0 % |
Operating Margin | -856.1 % |
Return on Assets (ttm) | -35.6 % |
Return on Equity (ttm) | -63.2 % |
Qtrly Rev. Growth | 44 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0.02 |
EBITDA (p.s.) | -0.17 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -6 (M) |
Levered Free Cash Flow | -3 (M) |
PE Ratio | -2.25 |
PEG Ratio | 0 |
Price to Book value | 2.04 |
Price to Sales | 21.35 |
Price to Cash Flow | -4.58 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |